Trial Profile

Phase 3 study of STA363

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 23 Feb 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Lactic acid (Primary)
Indications Back pain
Focus Therapeutic Use

Most Recent Events

23 Feb 2023 New trial record
22 Feb 2023 According to a Stayble Therapeutics media release, Detailed phase 3 planning via partnership is expected in H2 2024.
21 Feb 2023 According to a Stayble Therapeutics media release, the company will initiate dialogues with both the US (FDA) and Swedish (MPA) regulatory authorities in the first quarter to discuss design a Phase III clinical program.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com